Kingfa Science & Technology Intrinsic Value
KINGFA • Industrial Products
Current Stock Price
₹4229.60
Primary Intrinsic Value
₹1574.40
Market Cap
₹5076 Cr
-62.8%
Downside
Median Value
₹1574.40
Value Range
₹846 - ₹2240
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
KINGFA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1574.40 | ₹1259.52 - ₹1889.28 | -62.8% | EPS: ₹131.20, Sector P/E: 12x |
| Book Value Method | asset | ₹845.92 | ₹761.33 - ₹930.51 | -80.0% | Book Value/Share: ₹607.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1268.88 | ₹1141.99 - ₹1395.77 | -70.0% | Revenue/Share: ₹1585.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1691.84 | ₹1522.66 - ₹1861.02 | -60.0% | EBITDA: ₹256.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1691.84 | ₹1353.47 - ₹2030.21 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹2099.20 | ₹1889.28 - ₹2309.12 | -50.4% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹1268.88 | ₹1141.99 - ₹1395.77 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹2240.00 | ₹2016.00 - ₹2464.00 | -47.0% | ROE: 23.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1268.88 | ₹1141.99 - ₹1395.77 | -70.0% | EPS: ₹131.20, BVPS: ₹607.50 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
KINGFA Intrinsic Value Analysis
What is the intrinsic value of KINGFA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Kingfa Science & Technology (KINGFA) is ₹1574.40 (median value). With the current market price of ₹4229.60, this represents a -62.8% variance from our estimated fair value.
The valuation range spans from ₹845.92 to ₹2240.00, indicating ₹845.92 - ₹2240.00.
Is KINGFA undervalued or overvalued?
Based on our multi-method analysis, Kingfa Science & Technology (KINGFA) appears to be trading above calculated value by approximately 62.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 170.80 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 23.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.65x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Kingfa Science & Technology
Additional stock information and data for KINGFA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹60 Cr | ₹45 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹16 Cr | ₹16 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹27 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹38 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-2 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |